SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001493152-22-021494
Filing Date
2022-08-05
Accepted
2022-08-05 16:06:33
Documents
11

Document Format Files

Seq Description Document Type Size
1 forms-3.htm S-3 307421
2 ex5-1.htm EX-5.1 12582
3 ex23-1.htm EX-23.1 890
4 ex23-2.htm EX-23.2 4658
5 ex23-3.htm EX-23.3 3249
6 ex107.htm EX-FILING FEES 66055
7 logo_01.jpg GRAPHIC 5152
8 ex23-2_001.jpg GRAPHIC 3708
9 ex23-2_002.jpg GRAPHIC 3867
10 ex23-2_003.jpg GRAPHIC 10067
11 ex23-1_001.jpg GRAPHIC 79590
  Complete submission text file 0001493152-22-021494.txt   537560
Mailing Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103
Business Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103 239-302-1707
Enveric Biosciences, Inc. (Filer) CIK: 0000890821 (see all company filings)

IRS No.: 954484725 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-266579 | Film No.: 221140796
SIC: 2834 Pharmaceutical Preparations